It was shown that the percentage of CD14+CD16++ non-classical monocytes was decreased in individuals with stable CAD and five or more cardiovascular risk factors, suggesting that this subset might be protective for CVD development [35]. This evidence concerns the gene CD14 and coronary artery disorder.